As the average life expectancy continues to climb globally, an increasing proportion of the population are hitting and surpassing the post-60 milestone — with a 2024 statistic from the UN Department of Economic and Social Affairs estimating that 1.2 billion people worldwide are in this age category. Following this worldwide shift in age dynamics comes a higher prevalence of age-related conditions such as arthritis and osteoporosis.
Although there are pharmaceuticals suitable for those suffering from chronic bone and joint conditions, many older individuals are turning away from these types of solutions in favour of natural, clinically proven and effective ingredients — including a wide range of botanicals and animal-based extracts. To date, a vast variety of nutraceuticals have shown great promise in this category, including Boswellia serrata, ginger, palm tocotrienols and omega-3.
However, the interest in bone and joint health doesn’t stop at the older demographic, as many younger individuals are now looking for joint and bone health supplements to preempt issues later in life. By taking care of their skeleton before any problems arise, consumers are fighting off morning stiffness, cracking knees after workouts and general skeletal ageing.
According to natural ingredients provider Galam, the synergistic combination of short-chain fructooligosaccharides (sc-FOS) and collagen is the ideal solution for optimal joint and bone health.
Collagen and short-chain fructooligosaccharides: how the synergistic combo can support bone and joint health
Supplementing with a combination of prebiotic fructooligosaccharides (FOS) and collagen peptides promotes bone and joint health through enhanced mineral absorption and structural maintenance support
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
How prebiotic fructooligosaccharides and GLP-1 work synergistically to support metabolic health
Read moreFructooligosaccharides (FOS) have been shown to significantly increase blood GLP-1 levels, suggesting their synergistic potential — alongside GLP-1 receptor agonists — to manage obesity, type II diabetes and other metabolic diseases
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Ingredients
How prebiotic fructooligosaccharides and GLP-1 work synergistically to support metabolic health
Fructooligosaccharides (FOS) have been shown to significantly increase blood GLP-1 levels, suggesting their synergistic potential — alongside GLP-1 receptor agonists — to manage obesity, type II diabetes and other metabolic diseases
Ingredients
Short-chain fructo-oligosaccharides and their effect on the immune system
In the last decade, mainly owing to increasing demand for sugar reduction and fibre enrichment in the food and beverage industry, the global dietary fibre market has witnessed significant growth. Many of these ingredients are also recognised as prebiotics, which offer a wide range of gut and immune health benefits